SLGL (Sol-Gel Technologies) Institutional Ownership: 38.60% (As of Jul. 02, 2026)


SLGL Sol-Gel Technologies Ltd SLGL
56 GF Score
Price $73.40
GF Value $65.57
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is Sol-Gel Technologies Institutional Ownership?

Sol-Gel Technologies SLGL +2.72% 56 Institutional Ownership is 38.60% as of Jul. 02, 2026. GuruFocus rates SLGL with a GF Score™ of 56/100 and a GF Value™ of $65.57 (Modestly Overvalued). The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Sol-Gel Technologies's institutional ownership is 38.60%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Sol-Gel Technologies's Insider Ownership is 4.43%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Sol-Gel Technologies's Float Percentage Of Total Shares Outstanding is 32.20%.

Sol-Gel Technologies Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Sol-Gel Technologies's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sol-Gel Technologies Institutional Ownership Chart

Sol-Gel Technologies Historical Data

The historical data trend for Sol-Gel Technologies can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 3.97 3.97 3.97 4.03 4.18 0.31 0.28 0.28 0.26 0.31
SLGL
56GF Score
Sol-Gel Technologies Ltd SLGL
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sol-Gel Technologies Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 38.60% mean?
Sol-Gel Technologies (SLGL) has a Institutional Ownership of 38.60% as of Jul. 02, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Sol-Gel Technologies and its competitors.
Is Sol-Gel Technologies' Institutional Ownership too high?
Sol-Gel Technologies' current Institutional Ownership is 38.60%. Overall, Sol-Gel Technologies has a GF Score™ of 56/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sol-Gel Technologies' Institutional Ownership compare to AVXL and FATE?
Sol-Gel Technologies' Institutional Ownership of 38.60% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Sol-Gel Technologies and its competitors. Sol-Gel Technologies's current Institutional Ownership is 38.60%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sol-Gel Technologies stock overvalued right now?
Based on GuruFocus' analysis, Sol-Gel Technologies (SLGL) is currently considered Modestly Overvalued. The stock's GF Value™ is $65.57, compared to a current price of $73.40 — trading 11.9% above its estimated fair value. The current Institutional Ownership is 38.60%. Sol-Gel Technologies' overall GF Score™ is 56/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Sol-Gel Technologies (SLGL), the current Institutional Ownership is 38.60% as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sol-Gel Technologies (SLGL) Overvalued in 2026?

Based on GuruFocus' analysis, Sol-Gel Technologies stock appears to be overvalued. The current stock price of $73.40 is trading 11.9% above its estimated GF Value™ of $65.57. GuruFocus considers Sol-Gel Technologies to be Modestly Overvalued.

Key valuation signals for SLGL:

  • Institutional Ownership: 38.60%
  • GF Value™: $65.57 vs. price of $73.40 (11.9% above fair value)
  • GF Score™: 56/100 with 2 warning signs

No single metric tells the full story. See the SLGL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sol-Gel Technologies Business Description

Other Exchanges 4SG:Germany
Address 7 Golda Meir Street, Weizmann Science Park, Ness Ziona, ISR, 7403650
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted. It generates the majority of its revenue from the United States.
56GF Score

Get the complete analysis for SLGL

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$73.40
Price
$65.57
GF Value